{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:37:03Z","timestamp":1755797823590,"version":"3.44.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Anzhen Hospital High Level Research Funding","award":["2024AZC3001"],"award-info":[{"award-number":["2024AZC3001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06979-1","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T12:17:02Z","timestamp":1755519422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment and evaluation of a patient-derived organoids-based xenograft model of primary aldosteronism using [18F]AlF-NOTA-pentixather PET\/CT: bridging preclinical and clinical imaging"],"prefix":"10.1186","volume":"23","author":[{"given":"Xuezhou","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Mou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxuan","family":"Bo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingchuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhi","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8108-6910","authenticated-orcid":false,"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"9","key":"6979_CR1","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.124.22642","volume":"81","author":"GP Rossi","year":"2024","unstructured":"Rossi GP, Rossi FB, Guarnieri C, Rossitto G, Seccia TM. Clinical management of primary aldosteronism: an update. Hypertension. 2024;81(9):1845\u201356. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.124.22642.","journal-title":"Hypertension"},{"issue":"12","key":"6979_CR2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021;9(12):876\u201392. https:\/\/doi.org\/10.1016\/S2213-8587(21)00210-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6979_CR3","doi-asserted-by":"publisher","first-page":"6670183","DOI":"10.1155\/2021\/6670183","volume":"2021","author":"L Ma","year":"2021","unstructured":"Ma L, Zheng K, Yan J, Cheng W. Efficacy of ARB\/HCTZ combination therapy in uncontrolled hypertensive patients compared with ARB monotherapy: A Meta-Analysis. Int J Hypertens. 2021;2021:6670183. https:\/\/doi.org\/10.1155\/2021\/6670183.","journal-title":"Int J Hypertens"},{"issue":"11","key":"6979_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","volume":"18","author":"AF Turcu","year":"2022","unstructured":"Turcu AF, Yang J, Vaidya A. Primary aldosteronism - a multidimensional syndrome. Nat Rev Endocrinol. 2022;18(11):665\u201382. https:\/\/doi.org\/10.1038\/s41574-022-00730-2. Epub 2022 Aug 31.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"6979_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41574-020-0382-4","volume":"16","author":"MC Zennaro","year":"2020","unstructured":"Zennaro MC, Boulkroun S, Fernandes-Rosa FL. Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol. 2020;16(10):578\u201389. https:\/\/doi.org\/10.1038\/s41574-020-0382-4.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"6979_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.066389","volume":"149","author":"GL Hundemer","year":"2024","unstructured":"Hundemer GL, Agharazii M, Madore F, Vaidya A, Brown JM, Leung AA, Kline GA, Larose E, Pich\u00e9 ME, Crean AM, Shaw JLV, Ramsay T, Hametner B, Wassertheurer S, Sood MM, Hiremath S, Ruzicka M, Goupil R. Subclinical primary aldosteronism and cardiovascular health: A Population-Based cohort study. Circulation. 2024;149(2):124\u201334. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.066389.","journal-title":"Circulation"},{"issue":"1","key":"6979_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1210\/endrev\/bnad026","volume":"45","author":"N Mullen","year":"2024","unstructured":"Mullen N, Curneen J, Donlon PT, Prakash P, Bancos I, Gurnell M, Dennedy MC. Treating primary Aldosteronism-Induced hypertension: novel approaches and future outlooks. Endocr Rev. 2024;45(1):125\u201370. https:\/\/doi.org\/10.1210\/endrev\/bnad026.","journal-title":"Endocr Rev"},{"issue":"2","key":"6979_CR8","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3390\/ijms25020900","volume":"25","author":"N Ekman","year":"2024","unstructured":"Ekman N, Grossman AB, Dworakowska D. What we know about and what is new in primary aldosteronism. Int J Mol Sci. 2024;25(2):900. https:\/\/doi.org\/10.3390\/ijms25020900.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6979_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/fampra\/cmae033","volume":"41","author":"K Tsan","year":"2024","unstructured":"Tsan K, Yang J, Nainani A, Libianto R, Russell G. Screening for primary aldosteronism in primary care: a scoping review. Fam Pract. 2024;41(5):851\u20136. https:\/\/doi.org\/10.1093\/fampra\/cmae033.","journal-title":"Fam Pract"},{"issue":"1","key":"6979_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11906-024-01319-y","volume":"27","author":"Z Dong","year":"2024","unstructured":"Dong Z, Song X, Jia M, Chen J, Zhang Y, Yu H, Ji Y, Shan L, Zhang T, Zheng C, Wen J, Xu X. Diagnosis of primary aldosteronism without discontinuation of interfering antihypertensive medications. Curr Hypertens Rep. 2024;27(1):4. https:\/\/doi.org\/10.1007\/s11906-024-01319-y.","journal-title":"Curr Hypertens Rep"},{"issue":"8","key":"6979_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","volume":"24","author":"R Polak","year":"2024","unstructured":"Polak R, Zhang ET, Kuo CJ. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment. Nat Rev Cancer. 2024;24(8):523\u201339. https:\/\/doi.org\/10.1038\/s41568-024-00706-6.","journal-title":"Nat Rev Cancer"},{"key":"6979_CR12","doi-asserted-by":"publisher","first-page":"108744","DOI":"10.1016\/j.envint.2024.108744","volume":"188","author":"J Cong","year":"2024","unstructured":"Cong J, Wu J, Fang Y, Wang J, Kong X, Wang L, Duan Z. Application of organoid technology in the human health risk assessment of microplastics: A review of progresses and challenges. Environ Int. 2024;188:108744. https:\/\/doi.org\/10.1016\/j.envint.2024.108744.","journal-title":"Environ Int"},{"issue":"2","key":"6979_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41591-024-03489-3","volume":"31","author":"MMA Verstegen","year":"2025","unstructured":"Verstegen MMA, Coppes RP, Beghin A, De Coppi P, Gerli MFM, de Graeff N, Pan Q, Saito Y, Shi S, Zadpoor AA, van der Laan LJW. Clinical applications of human organoids. Nat Med. 2025;31(2):409\u201321. https:\/\/doi.org\/10.1038\/s41591-024-03489-3.","journal-title":"Nat Med"},{"issue":"3","key":"6979_CR14","doi-asserted-by":"publisher","first-page":"100620","DOI":"10.1016\/j.xinn.2024.100620","volume":"5","author":"X Han","year":"2024","unstructured":"Han X, Cai C, Deng W, Shi Y, Li L, Wang C, Zhang J, Rong M, Liu J, Fang B, He H, Liu X, Deng C, He X, Cao X. Landscape of human organoids: ideal model in clinics and research. Innov (Camb). 2024;5(3):100620. https:\/\/doi.org\/10.1016\/j.xinn.2024.100620.","journal-title":"Innov (Camb)"},{"issue":"6","key":"6979_CR15","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1097\/HEP.0000000000000343","volume":"79","author":"MB Afonso","year":"2024","unstructured":"Afonso MB, Marques V, van Mil SWC, Rodrigues CMP. Human liver organoids: from generation to applications. Hepatology. 2024;79(6):1432\u201351. https:\/\/doi.org\/10.1097\/HEP.0000000000000343.","journal-title":"Hepatology"},{"issue":"3","key":"6979_CR16","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.7150\/thno.91362","volume":"14","author":"J Lv","year":"2024","unstructured":"Lv J, Du X, Wang M, Su J, Wei Y, Xu C. Construction of tumor organoids and their application to cancer research and therapy. Theranostics. 2024;14(3):1101\u201325. https:\/\/doi.org\/10.7150\/thno.91362.","journal-title":"Theranostics"},{"issue":"1","key":"6979_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/clinem\/dgad421","volume":"109","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Long T, Peng N, Zhen M, Ye Q, Zhang Z, He Y, Chen Z, Gan Y, Luo M, Li C, Liu Z, Guo M, Wang M, Luo X, Hu S, Liu L, Jiang T. The value of targeting CXCR4 with 68Ga-Pentixafor PET\/CT for subtyping primary aldosteronism. J Clin Endocrinol Metab. 2023;109(1):171\u201382. https:\/\/doi.org\/10.1210\/clinem\/dgad421.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"6979_CR18","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","volume":"47","author":"J Ding","year":"2020","unstructured":"Ding J, Zhang Y, Wen J, Zhang H, Wang H, Luo Y, Pan Q, Zhu W, Wang X, Yao S, Kreissl MC, Hacker M, Tong A, Huo L, Li X. Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. Eur J Nucl Med Mol Imaging. 2020;47(11):2656\u201365. https:\/\/doi.org\/10.1007\/s00259-020-04722-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"6979_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.18383\/j.tom.2016.00130","volume":"2","author":"A Poschenrieder","year":"2016","unstructured":"Poschenrieder A, Osl T, Schottelius M, Hoffmann F, Wirtz M, Schwaiger M, Wester HJ. First 18F-Labeled Pentixafor-Based imaging agent for PET imaging of CXCR4 expression in vivo. Tomography. 2016;2(2):85\u201393. https:\/\/doi.org\/10.18383\/j.tom.2016.00130.","journal-title":"Tomography"},{"issue":"19","key":"6979_CR20","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.7150\/thno.100848","volume":"14","author":"L He","year":"2024","unstructured":"He L, Yang Y, Cao X, Zhu X, Liu N, Chen X, Zhang J, Zhang W. [18F]AlF-NOTA-pentixather PET\/CT of CXCR4 in patients with suspected primary hyperaldosteronism. Theranostics. 2024;14(19):7281\u201391. https:\/\/doi.org\/10.7150\/thno.100848.","journal-title":"Theranostics"},{"issue":"Pt 3","key":"6979_CR21","doi-asserted-by":"publisher","first-page":"142079","DOI":"10.1016\/j.ijbiomac.2025.142079","volume":"307","author":"X Zhang","year":"2025","unstructured":"Zhang X, Hong B, Yu W, Miao Q, Wang W, Wang Y, Sun Z, Bo Y, Zhang J, Zhang H, Zhang N. Comprehensive pan-cancer analysis reveals CD70 as a promising therapeutic target and biomarker in clear cell renal cell carcinoma. Int J Biol Macromol. 2025;307(Pt 3):142079. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142079.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"6979_CR22","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1161\/HYPERTENSIONAHA.121.18761","volume":"79","author":"JW Funder","year":"2022","unstructured":"Funder JW, Carey RM. Primary aldosteronism: where are we now?? where to from here?? Hypertension. 2022;79(4):726\u201335. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.18761.","journal-title":"Hypertension"},{"issue":"1","key":"6979_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11154-022-09729-6","volume":"24","author":"V Forestiero","year":"2023","unstructured":"Forestiero V, Sconfienza E, Mulatero P, Monticone S. Primary aldosteronism in pregnancy. Rev Endocr Metab Disord. 2023;24(1):39\u201348. https:\/\/doi.org\/10.1007\/s11154-022-09729-6.","journal-title":"Rev Endocr Metab Disord"},{"issue":"12","key":"6979_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11906-023-01269-x","volume":"25","author":"R Zuo","year":"2023","unstructured":"Zuo R, Liu S, Xu L, Pang H. Key to the treatment of primary aldosteronism in secondary hypertension: subtype diagnosis. Curr Hypertens Rep. 2023;25(12):471\u201380. https:\/\/doi.org\/10.1007\/s11906-023-01269-x.","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"6979_CR25","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1161\/STROKEAHA.120.033990","volume":"52","author":"J McCarthy","year":"2021","unstructured":"McCarthy J, Yang J, Clissold B, Young MJ, Fuller PJ, Phan T. Hypertension management in stroke prevention: time to consider primary aldosteronism. Stroke. 2021;52(10):e626\u201334. https:\/\/doi.org\/10.1161\/STROKEAHA.120.033990.","journal-title":"Stroke"},{"issue":"22","key":"6979_CR26","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1016\/j.jacc.2019.09.057","volume":"74","author":"GP Rossi","year":"2019","unstructured":"Rossi GP. Primary aldosteronism: JACC State-of-the-Art review. J Am Coll Cardiol. 2019;74(22):2799\u2013811. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.057.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"6979_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3803\/EnM.2018.33.4.429","volume":"33","author":"ZW Chen","year":"2018","unstructured":"Chen ZW, Hung CS, Wu VC, Lin YH, TAIPAI study group. Primary aldosteronism and cerebrovascular diseases. Endocrinol Metab (Seoul). 2018;33(4):429\u201334. https:\/\/doi.org\/10.3803\/EnM.2018.33.4.429.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"4","key":"6979_CR28","first-page":"2689","volume":"14","author":"Z Chen","year":"2022","unstructured":"Chen Z, Zhang Z, Xi Q, Huang G, Wang L. Curable congestive heart failure in patients with primary aldosteronism: two cases reports. Am J Transl Res. 2022;14(4):2689\u201396.","journal-title":"Am J Transl Res"},{"issue":"7","key":"6979_CR29","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41371-020-0336-2","volume":"34","author":"R Libianto","year":"2020","unstructured":"Libianto R, Fuller PJ, Young MJ, Yang J. Primary aldosteronism is a public health issue: challenges and opportunities. J Hum Hypertens. 2020;34(7):478\u201386. https:\/\/doi.org\/10.1038\/s41371-020-0336-2.","journal-title":"J Hum Hypertens"},{"issue":"5","key":"6979_CR30","doi-asserted-by":"publisher","first-page":"e230115","DOI":"10.1148\/rg.230115","volume":"44","author":"K Kobayashi","year":"2024","unstructured":"Kobayashi K, Alkukhun L, Rey E, Salaskar A, Acharya R. Adrenal vein sampling: tips and tricks. Radiographics. 2024;44(5):e230115. https:\/\/doi.org\/10.1148\/rg.230115.","journal-title":"Radiographics"},{"key":"6979_CR31","doi-asserted-by":"publisher","first-page":"797021","DOI":"10.3389\/fendo.2022.797021","volume":"13","author":"S Zhong","year":"2022","unstructured":"Zhong S, Zhang T, He M, Yu H, Liu Z, Li Z, Song X, Xu X. Recent advances in the clinical application of adrenal vein sampling. Front Endocrinol (Lausanne). 2022;13:797021. https:\/\/doi.org\/10.3389\/fendo.2022.797021.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"6979_CR32","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1161\/HYPERTENSIONAHA.123.21563","volume":"80","author":"JM Luther","year":"2023","unstructured":"Luther JM, Turcu AF. Unilaterally successful adrenal vein sampling: use or repeat?? Hypertension. 2023;80(10):2014\u20136. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.21563.","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"6979_CR33","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1148\/rg.25si055514","volume":"25","author":"N Daunt","year":"2005","unstructured":"Daunt N. Adrenal vein sampling: how to make it quick, easy, and successful. Radiographics. 2005;25(Suppl 1):S143\u201358. https:\/\/doi.org\/10.1148\/rg.25si055514.","journal-title":"Radiographics"},{"issue":"11","key":"6979_CR34","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1007\/s00330-019-06209-5","volume":"29","author":"A Lupi","year":"2019","unstructured":"Lupi A, Battistel M, Barbiero G, Miotto D, Rossi GP, Quaia E. Simultaneous bilateral adrenal vein sampling for primary aldosteronism: useful tips to make it simple and safe. Eur Radiol. 2019;29(11):6330\u20135. https:\/\/doi.org\/10.1007\/s00330-019-06209-5.","journal-title":"Eur Radiol"},{"issue":"1","key":"6979_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","volume":"106","author":"TA Williams","year":"2021","unstructured":"Williams TA, Gomez-Sanchez CE, Rainey WE, Giordano TJ, Lam AK, Marker A, Mete O, Yamazaki Y, Zerbini MCN, Beuschlein F, Satoh F, Burrello J, Schneider H, Lenders JWM, Mulatero P, Castellano I, Kn\u00f6sel T, Papotti M, Saeger W, Sasano H, Reincke M. International histopathology consensus for unilateral primary aldosteronism. J Clin Endocrinol Metab. 2021;106(1):42\u201354. https:\/\/doi.org\/10.1210\/clinem\/dgaa484.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6979_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","volume":"71","author":"B Heinze","year":"2018","unstructured":"Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, Schirbel A, Deutschbein T, Williams TA, Rhayem Y, Quinkler M, Rayes N, Monticone S, Wild V, Gomez-Sanchez CE, Reis AC, Petersenn S, Wester HJ, Kropf S, Fassnacht M, Lang K, Herrmann K, Buck AK, Bluemel C, Hahner S. Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of Aldosterone-Producing adenoma. Hypertension. 2018;71(2):317\u201325. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09975.","journal-title":"Hypertension"},{"issue":"4","key":"6979_CR37","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/RLU.0000000000002946","volume":"45","author":"J Ding","year":"2020","unstructured":"Ding J, Tong A, Zhang Y, Wen J, Huo L. Intense 68Ga-Pentixafor activity in Aldosterone-Producing adrenal adenomas. Clin Nucl Med. 2020;45(4):336\u20139. https:\/\/doi.org\/10.1097\/RLU.0000000000002946.","journal-title":"Clin Nucl Med"},{"issue":"9","key":"6979_CR38","first-page":"10009","volume":"10","author":"C Chu","year":"2017","unstructured":"Chu C, Zhao C, Zhang Z, Wang M, Zhang Z, Yang A, Ma B, Gu M, Cui R, Xin Z, Huang T, Zhou W. Transcriptome analysis of primary aldosteronism in adrenal glands and controls. Int J Clin Exp Pathol. 2017;10(9):10009\u201318.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"6979_CR39","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1038\/s41598-019-41525-2","volume":"9","author":"S Backman","year":"2019","unstructured":"Backman S, \u00c5kerstr\u00f6m T, Maharjan R, Cupisti K, Willenberg HS, Hellman P, Bj\u00f6rklund P. RNA sequencing provides novel insights into the transcriptome of aldosterone producing adenomas. Sci Rep. 2019;9(1):6269. https:\/\/doi.org\/10.1038\/s41598-019-41525-2.","journal-title":"Sci Rep"},{"issue":"2","key":"6979_CR40","doi-asserted-by":"publisher","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","volume":"6","author":"J Hu","year":"2023","unstructured":"Hu J, Xu T, Shen H, Song Y, Yang J, Zhang A, Ding H, Xing N, Li Z, Qiu L, Ma L, Yang Y, Feng Z, Du Z, He W, Sun Y, Cai J, Li Q, Chen Y, Yang S. Chongqing primary aldosteronism study (CONPASS) group. Accuracy of Gallium-68 pentixafor positron emission tomography-Computed tomography for subtyping diagnosis of primary aldosteronism. JAMA Netw Open. 2023;6(2):e2255609. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55609.","journal-title":"JAMA Netw Open"},{"key":"6979_CR41","doi-asserted-by":"publisher","first-page":"1291775","DOI":"10.3389\/fendo.2024.1291775","volume":"15","author":"X Yin","year":"2024","unstructured":"Yin X, Ai K, Luo J, Liu W, Ma X, Zhou L, Xiang X, Su X, Wang Y, Li Y. A comparison of the performance of 68Ga-Pentixafor PET\/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism. Front Endocrinol (Lausanne). 2024;15:1291775. https:\/\/doi.org\/10.3389\/fendo.2024.1291775.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06979-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06979-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06979-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:03:32Z","timestamp":1755561812000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06979-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6979"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06979-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"type":"electronic","value":"1479-5876"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"and consent of participate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This research received approval from the Ethics Committee of Beijing Anzhen Hospital (Approval No.: 2025AZB5002). All participants gave written informed consent. The study was conducted in accordance with the principles outlined in the Declaration of Helsinki. All animal procedures were approved by the Animal Care and Use Committee of Beijing Anzhen Hospital and conducted in accordance with institutional guidelines.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not Applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"927"}}